Abner Herrman & Brock LLC decreased its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 22.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,350 shares of the company's stock after selling 7,200 shares during the period. Abner Herrman & Brock LLC's holdings in Procter & Gamble were worth $3,879,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Nova Wealth Management Inc. bought a new position in shares of Procter & Gamble in the 1st quarter valued at about $26,000. Capital A Wealth Management LLC bought a new stake in Procter & Gamble in the fourth quarter worth about $31,000. Quarry LP bought a new stake in Procter & Gamble in the first quarter worth about $33,000. 10Elms LLP bought a new stake in Procter & Gamble in the fourth quarter worth about $34,000. Finally, Mizuho Securities Co. Ltd. lifted its stake in Procter & Gamble by 566.7% in the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock worth $34,000 after purchasing an additional 170 shares during the last quarter. Institutional investors own 65.77% of the company's stock.
Procter & Gamble Stock Performance
Shares of PG stock opened at $158.02 on Friday. The firm has a market cap of $369.85 billion, a price-to-earnings ratio of 24.27, a PEG ratio of 4.19 and a beta of 0.36. The company's 50 day moving average is $156.21 and its 200 day moving average is $161.84. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 52-week low of $149.91 and a 52-week high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. The company had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. Procter & Gamble's revenue was up 1.7% compared to the same quarter last year. During the same period last year, the company posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is presently 64.98%.
Insider Activity at Procter & Gamble
In other Procter & Gamble news, CEO Gary A. Coombe sold 10,194 shares of Procter & Gamble stock in a transaction on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the transaction, the chief executive officer directly owned 34,978 shares of the company's stock, valued at approximately $5,532,120.48. The trade was a 22.57% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Marc S. Pritchard sold 9,849 shares of Procter & Gamble stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the completion of the transaction, the insider directly owned 182,422 shares in the company, valued at $28,689,507.94. This represents a 5.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 120,181 shares of company stock valued at $18,918,012 over the last quarter. 0.20% of the stock is owned by insiders.
Analysts Set New Price Targets
Several brokerages have issued reports on PG. Barclays set a $164.00 price objective on shares of Procter & Gamble and gave the stock an "equal weight" rating in a research note on Thursday, July 31st. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $170.00 price objective (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Evercore ISI reaffirmed an "in-line" rating and set a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. BNP Paribas reaffirmed an "outperform" rating and set a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. Finally, Wells Fargo & Company reduced their target price on shares of Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have issued a Hold rating to the company's stock. According to data from MarketBeat, Procter & Gamble currently has a consensus rating of "Moderate Buy" and an average price target of $175.12.
Check Out Our Latest Stock Report on Procter & Gamble
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.